ASCO Logo

New for ASCO 2020:
Abstracts, Experts, and a CAR-T Webinar with Investigators
from City of Hope

At Precision, we look forward to meeting our colleagues in oncology research at ASCO every year. In this most exceptional year, when we can’t see you in person, we’re sharing our three accepted ASCO abstracts, our leading experts, and an invitation to an exclusive webinar right here. Through 20+ years running successful oncology trials, Precision has developed a unique blend of proprietary technologies, flexible processes, and creative problem-solving abilities that advance even the most challenging clinical development programs.

ASCO Logo

New for ASCO 2020:
Abstracts, Experts, and a CAR-T Webinar with Investigators From City of Hope

At Precision, we look forward to meeting our colleagues in oncology research at ASCO every year. In this most exceptional year, when we can’t see you in person, we’re sharing our three accepted ASCO abstracts, our leading experts, and an invitation to an exclusive webinar right here. Through 20+ years running successful oncology trials, Precision has developed a unique blend of proprietary technologies, flexible processes, and creative problem-solving abilities that advance even the most challenging clinical development programs.

Schedule a Virtual ASCO Meeting with Our Experts

Learn More

Watch Our Exclusive CAR-T Webinar On-Demand

Learn More

View Accepted ASCO Abstract Presentations

Learn More

Expert Advice for Your Oncology Trials

ASCO offers a tremendous opportunity to get insightful advice on your research and development issues—and this year is no exception. Our experts look forward to providing the same valuable guidance in virtual meetings over the coming days.

Pat Devitt Risse, PharmD Portrait

Pat Devitt Risse, PharmD
President, Clinical Solutions

Clare Sarvary Fourrier Portrait

Clare Sarvary Fourrier
Senior Vice President, Clinical Operations, Europe

Deborah Phippard, PhD Portrait

Deborah Phippard, PhD
Senior Vice President,
Research Services

Gerald Messerschmidt, MD, FACP Portrait

Gerald Messerschmidt,
MD, FACP
Chief Medical Officer

Al Blunt, MD Portrait

Al Blunt, MD
Senior Vice President,
Medical, Americas

Megan Liles, MS Portrait

Megan Liles, MS
Executive Director, Operational Strategy & Feasibility

To schedule your meeting, please click the link below, then use the contact form to indicate which expert you would like to meet and some times that are convenient.

Watch Our Exclusive CAR-T Webinar With Experts From City of Hope

An exclusive panel discussion with two leading researchers from the City of Hope Cancer Center. They will present recent research into CAR-T therapy for both hematologic malignancies and solid tumors, then engage in a question-and-answer session.

Attendees of this webinar will get an inside look at:

  • Lessons from Phase 1 trials: reverse translation
  • Overcoming tumor antigen escape/immunosuppression
  • Improving persistence/survival of T cells in challenging solid tumors (next-gen CARs)

CAR-T for Hematology and Solid Tumors: Experience from City of Hope

Accepted ASCO Abstracts

These three abstracts were accepted by ASCO for publication this year. They span important and timely oncology topics, including:

1. How to more precisely define the dose range testing in humans

2. The exciting new immune and targeted therapies being developed – and the challenges they face

3. STING Agonist and the implications for clinical trial design

They are available for you to view at your convenience below:

Click on Image to View

Dosing

Immune

STING

Oncology Expertise That Spans the Globe

Our 20+ years of successful global oncology and immuno-oncology trials stem from our unique blend of proprietary technologies, logistical expertise, and an expert team.

Map
Infographic